These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2083056)

  • 21. BSE--a risk for man through pharmaceutical products? Position and politics of the German pharmaceutical industry.
    Danner K
    Dev Biol Stand; 1993; 80():199-205. PubMed ID: 8270110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood transfusion in Europe: basic principles for initial and continuous training in transfusion medicine: an approach to an European harmonisation.
    Mueller MM; Seifried E
    Transfus Clin Biol; 2006 Nov; 13(5):282-5; quiz 286-9. PubMed ID: 17196864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of biotechnology products in the global pharmaceutical market: the case of the European community and the United States.
    Hakim Z; Kucukarslan S
    Clin Ther; 1993; 15(2):442-58; discussion 432. PubMed ID: 8519050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Microbiologic validation in the production of sterile pharmaceuticals].
    Pongiluppi S
    Boll Chim Farm; 1991 Jun; 130(6):203-12. PubMed ID: 1756004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Payers growing influence on R&D decision making.
    Hughes B
    Nat Rev Drug Discov; 2008 Nov; 7(11):876-8. PubMed ID: 18974741
    [No Abstract]   [Full Text] [Related]  

  • 26. On macroeconomic characteristics of pharmaceutical generics and the potential for manufacturing and consumption under fuzzy conditions.
    Gascón F; de la Fuente D; Puente J; Lozano J
    Artif Intell Med; 2007 Nov; 41(3):223-35. PubMed ID: 17719212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Industry Perspective of Pediatric Drug Development in the United States: Involvement of the European Union Countries.
    Onishi T; Tsukamoto K; Matsumaru N; Waki T
    Ther Innov Regul Sci; 2018 Jan; 52(1):49-56. PubMed ID: 29714619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. When medicine becomes a disease.
    Arabia; 1986 Mar; 5(55):32-6. PubMed ID: 12340711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implications of international drug approval systems on confidentiality of business secrets in the U.S. pharmaceutical industry.
    O'Reilly JT
    Food Drug Law J; 1998; 53(1):123-32. PubMed ID: 11795328
    [No Abstract]   [Full Text] [Related]  

  • 30. Compensation of occupational diseases and particularly of asbestos-related diseases among the European Community (EEC) countries.
    Merler E; Brizzi S
    Epidemiol Prev; 1994 Sep; 18(60):170-9. PubMed ID: 7805824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using the WTO/TBT enquiry point to monitor tendencies in the regulation of environment, health, and safety issues affecting the chemical industry.
    Pio Borges Menezes R; Maria de Souza Antunes A
    Environ Int; 2005 Apr; 31(3):407-16. PubMed ID: 15734193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Changes in the norms governing practices for the manufacture of pharmaceutical products: implications for the MERCOSUR].
    Temprano G; Prats S; Bregni C
    Boll Chim Farm; 1998 Nov; 137(10):426-38. PubMed ID: 9880947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmaceutical policy in Italy: towards a structural change?
    Ghislandi S; Krulichova I; Garattini L
    Health Policy; 2005 Apr; 72(1):53-63. PubMed ID: 15760698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Two years with EMEA: towards a unified drug registration within the EEC].
    Lennholm B
    Lakartidningen; 1997 Jan; 94(1-2):8-12. PubMed ID: 9053613
    [No Abstract]   [Full Text] [Related]  

  • 35. Developing a European framework for research on children's medicines: an examination of the proposed EU regulation on medicinal products for paediatric use.
    Seyberth HW; Demotes-Mainard J; Wrobel P
    Pediatr Nephrol; 2005 Nov; 20(11):1537-40. PubMed ID: 16167134
    [No Abstract]   [Full Text] [Related]  

  • 36. European regulations relevant to the marketing and use of fish vaccines.
    Lee A
    Dev Biol Stand; 1997; 90():341-6. PubMed ID: 9270862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. No immediate pain relief for the pharmaceutical industry.
    Ahlborn H; Henderson S; Davies N
    Curr Opin Drug Discov Devel; 2005 May; 8(3):384-91. PubMed ID: 15892254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 2 billion euro IMI launched with European pharma.
    Hodgson J
    Nat Biotechnol; 2008 Jul; 26(7):717-8. PubMed ID: 18612274
    [No Abstract]   [Full Text] [Related]  

  • 39. [Drug control within the EEC I: coordination during the 1990's].
    Strandberg K
    Lakartidningen; 1992 Jan; 89(3):100-1. PubMed ID: 1734132
    [No Abstract]   [Full Text] [Related]  

  • 40. New safe medicines faster: A proposal for a key action within the European union's 6th framework programme.
    Bjerrum OJ
    Pharmacol Toxicol; 2000; 86 Suppl 1():23-6. PubMed ID: 10905750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.